Iridium Network Reaches a Milestone with RayCare and TrueBeam
Iridium Network has garnered attention as the first center globally to successfully implement RaySearch's oncology information system, RayCare®, alongside the Varian TrueBeam® linear accelerator for patient treatments. This significant milestone underscores the network's commitment to delivering cutting-edge cancer care to its patients.
About Iridium Network
Founded in 2006, Iridium Network has quickly become the largest radiotherapy network in its region, specializing in radiation oncology services. With ten TrueBeam linear accelerators across four locations, the network treats over 6,000 patients each year, establishing itself as a leader in cancer treatment.
The Development of RayCare
The partnership between Iridium Network and RaySearch has evolved over several years, starting when they became clinical affiliates in 2015. The network played a crucial role in shaping RayCare, and by 2018, it was the first institution to implement RayCare clinically, just months after its public release. This forward-thinking approach has positioned Iridium Network at the forefront of oncology care.
Clinical Milestones
Recently, Iridium Network received an interoperability certificate for RayCare 2024A and the TrueBeam family of linear accelerators, confirming their seamless integration. This achievement reinforces the network's dedication to providing state-of-the-art medical solutions and highlights its contributions to advancing cancer treatment methodologies.
Insights from Medical Experts
Dr. Piet Dirix, a Radiation Oncologist at Iridium Network, expressed enthusiasm about the development of RayCare. He shared, "Our team is excited to have been involved in creating RayCare, which acts as a comprehensive oncology information system that integrates all facets of cancer care. Our aim is to streamline oncology workflows, improving the experience for both patients and healthcare providers."
Innovating Cancer Care
Prof. Dirk Verellen, Director of Medical Physics at Iridium Network, noted that RayCare promotes consistency and automation in patient care. "This system is essential for upholding high standards of patient safety, treatment efficiency, and overall care quality. We are dedicated to delivering groundbreaking radiation oncology therapies while focusing on patient outcomes," he remarked.
A Collaborative Effort for Progress
Johan Löf, Founder and CEO of RaySearch, commended the partnership between RaySearch and Iridium Network. He stated, "RayCare exemplifies the strength of our collaboration with clinical experts in developing an integrated oncology information system. Connecting RayCare with TrueBeam today highlights our mutual commitment to enhancing cancer care with a patient-centered approach. This is indeed a landmark moment for both organizations."
Contact Us for More Information
If you would like further insights and details about the innovative work being done at Iridium Network and RaySearch Laboratories, please reach out to:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
Frequently Asked Questions
What is RayCare?
RayCare is an advanced oncology information system created by RaySearch Laboratories, aimed at enhancing workflows and integrating various disciplines of cancer care.
What is the TrueBeam system?
TrueBeam is a cutting-edge linear accelerator utilized in radiation therapy, designed to deliver highly precise treatments for cancer patients.
Why is Iridium Network important?
Iridium Network stands out as the largest radiotherapy network in its region, recognized for its innovative treatment methods and collaborations with RaySearch.
How does RayCare improve patient care?
RayCare enhances consistency and automation, resulting in improved patient safety, efficiency, and overall quality of care in oncology environments.
Who can I contact for more information?
For any inquiries, please reach out to Johan Löf at RaySearch Laboratories using the provided email or telephone number.
